Grade 3 or 4 Astrocytoma
1 clinical trials · Condition
◉ Watch Grade 3 or 4 Astrocytoma
| Record | Firm | Date |
|---|---|---|
| Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma (NCT04782609) | Samus Therapeutics, Inc. | 2021-12-27 |
Track Grade 3 or 4 Astrocytoma automatically
Every clearance here is in the API, with alerts when new ones post.